| Literature DB >> 33402693 |
David W Cleary1,2, Denise E Morris3, Rebecca A Anderson3, Jessica Jones3, Ahmed Ghazi Alattraqchi4, Nor Iza A Rahman4, Salwani Ismail4, Mohd Sayuti Razali4, Rahmah Mohd Amin4, Aniza Abd Aziz4, Nor Kamaruzaman Esa4, Salman Amiruddin4, Ching Hoong Chew5, Hafis Simin6,7, Ramle Abdullah6, Chew Chieng Yeo4, Stuart C Clarke3,8,9,10,11.
Abstract
Much microbiome research has focused on populations that are predominantly of European descent, and from narrow demographics that do not capture the socio-economic and lifestyle differences which impact human health. Here we examined the airway microbiomes of the Orang Asli, the indigenous peoples of Malaysia. A total of 130 participants were recruited from two sites in the north-eastern state of Terengganu in Peninsular Malaysia. Using 16S rRNA sequencing, the nasal microbiome was significantly more diverse in those aged 5-17 years compared to 50+ years (p = 0.023) and clustered by age (PERMANOVA analysis of the Bray-Curtis distance, p = 0.001). Hierarchical clustering of Bray-Curtis dissimilarity scores revealed six microbiome clusters. The largest cluster (n = 28; 35.4%) had a marked abundance of Corynebacterium. In the oral microbiomes Streptococcus, Neisseria and Haemophilus were dominant. Using conventional microbiology, high levels of Staphylococcus aureus carriage were observed, particularly in the 18-65 age group (n = 17/36; 47.2% 95% CI: 30.9-63.5). The highest carriage of pneumococci was in the <5 and 5 to 17 year olds, with 57.1% (4/7) and 49.2% (30/61), respectively. Sixteen pneumococcal serotypes were identified, the most common being the nonvaccine-type 23A (14.6%) and the vaccine-type 6B (9.8%). The prevalence of pneumococcal serotypes covered by pneumococcal conjugate vaccines support introduction into a Malaysian national immunisation schedule. In addition, the dominance of Corynebacterium in the airway microbiomes is intriguing given their role as a potentially protective commensal with respect to acute infection and respiratory health.Entities:
Year: 2021 PMID: 33402693 PMCID: PMC7785749 DOI: 10.1038/s41522-020-00173-5
Source DB: PubMed Journal: NPJ Biofilms Microbiomes ISSN: 2055-5008 Impact factor: 7.290